The Oxford University-AstraZeneca covid vaccine is now undergoing Phase III clinical trials in Britain, Brazil, South Africa and India.
Serum Institute of India chief Adar Poonawalla remains optimistic on Oxford covid vaccine as the coronavirus pandemic claimed close to 9 lakh lives across the world. Viewed as a front-runner in the global race to deliver an effective vaccine to combat Covid-19, the Oxford University-AstraZeneca vaccine is now undergoing Phase III clinical trials in Britain, Brazil, South Africa and India.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.